FCRL6 distinguishes mature cytotoxic lymphocytes and is upregulated in patients with B-cell chronic lymphocytic leukemia

European Journal of Immunology

Volumn 38, Issue 11, 2008, Pages 3159-3166

  Schreeder, Daniel M ^a   Pan, Jicun ^b,c   Li, Fu Jun ^b,c   Vivier, Eric ^d,e,f,g   Davis, Randall S ^a,b,c,h  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c University of Alabama at Birmingham   (United States)

^d CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^e INSERM   (France)

^f CNRS   (France)

^g HÔPITAL DE LA CONCEPTION   (France)

^h UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Chronic lymphocytic leukemia; Fc receptor like; Human cytotoxic T cells; Human NK cells

Indexed keywords

CD56 ANTIGEN; FC RECEPTOR; FC RECEPTOR LIKE 6; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; FCRL6 PROTEIN, HUMAN;

ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL MEDIATED CYTOTOXICITY; CONTROLLED STUDY; CYTOTOXIC LYMPHOCYTE; HEMATOPOIETIC TISSUE; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE SUBPOPULATION; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SEQUENCE HOMOLOGY; T LYMPHOCYTE ACTIVATION; UPREGULATION; CHRONIC LYMPHATIC LEUKEMIA; IMMUNOLOGY; PHOSPHORYLATION; PHYSIOLOGY;

CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; HUMANS; KILLER CELLS, NATURAL; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; PHOSPHORYLATION; RECEPTORS, CELL SURFACE;

EID: 58149349906     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200838516     Document Type: Article

References (35)

1. Colucci, F., Caligiuri, M. A. and Di Santo, J. P., What does it take to make a natural killer? Nat. Rev. Immunol. 2003. 3: 413-425.
2. Angelini, D. F., Borsellino, G., Poupot, M., Diamantini, A., Poupot, R., Bernardi, G., Poccia, F. et al., FcgammaRIII discriminates between 2 subsets of Vgamma9Vdelta2 effector cells with different responses and activation pathways. Blood 2004. 104: 1801-1807.
3. Appay, V., Zaunders, J. J., Papagno, L., Sutton, J., Jaramillo, A., Waters, A., Easterbrook, P. et al., Characterization of CD41 CTLs ex vivo. J. Immunol. 2002. 168: 5954-5958.
4. Ravetch, J. V. and Lanier, L. L., Immune inhibitory receptors. Science 2000. 290: 84-89.
5. Mingari, M. C., Pietra, G. and Moretta, L., Human cytolytic T lymphocytes expressing HLA class-I-specific inhibitory receptors. Curr. Opin. Immunol. 2005. 17: 312-319.
6. Stewart, C. A., Vivier, E. and Colonna, M., Strategies of natural killer cell recognition and signaling. Curr. Top. Microbiol. Immunol. 2006. 298: 1-21.
7. Hatzivassiliou, G., Miller, I., Takizawa, J., Palanisamy, N., Rao, P. H., Iida, S., Tagawa, S. et al., IRTA1 and IRTA2, novel immunoglobulin superfamily receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B cell malignancy. Immunity 2001. 14: 277-289.
8. Davis, R. S., Wang, Y. H., Kubagawa, H. and Cooper, M. D., Identification of a family of Fc receptor homologs with preferential B cell expression. Proc. Natl. Acad. Sci. USA 2001. 98: 9772-9777.
9. Davis, R. S., Fc receptor-like molecules. Annu. Rev. Immunol. 2007. 25: 525-560.
10. Leu, C. M., Davis, R. S., Gartland, L. A., Fine, W. D. and Cooper, M. D., FcRH1: An activation coreceptor on human B cells. Blood 2005. 105: 1121-1126.
11. Ehrhardt, G. R., Davis, R. S., Hsu, J. T., Leu, C. M., Ehrhardt, A. and Cooper, M. D., The inhibitory potential of Fc receptor homolog 4 on memory B cells. Proc. Natl. Acad. Sci. USA 2003. 100: 13489-13494.
12. Davis, R. S., Dennis, G., Jr., Odom, M. R., Gibson, A. W., Kimberly, R. P., Burrows, P. D. and Cooper, M. D., Fc receptor homologs: Newest members of a remarkably diverse Fc receptor gene family. Immunol. Rev. 2002. 190: 123-136.
13. Ershova, S. A., Naiakshin, A. M., Mechetina, L. V., Peklo, M. M., Shevelev, A. I., Vlasik, T. N., Chikaev, N. A. and Taranin, A. V., [Expression patterns of the human and mouse IFGP family genes]. Mol. Biol. (Mosk) 2005. 39: 776-785.
14. Wilson, T. J., Presti, R. M., Tassi, I., Overton, E. T., Cella, M. and Colonna, M., FcRL6, a new ITIM-bearing receptor on cytolytic cells, is broadly expressed by lymphocytes following HIV-1 infection. Blood 2007. 109: 3786-3793.
15. Ferlazzo, G., Thomas, D., Lin, S. L., Goodman, K., Morandi, B., Muller, W. A., Moretta, A. and Munz, C., The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. J. Immunol. 2004. 172: 1455-1462.
16. Freud, A. G., Yokohama, A., Becknell, B., Lee, M. T., Mao, H. C., Ferketich, A. K. and Caligiuri, M. A., Evidence for discrete stages of human natural killer cell differentiation in vivo. J. Exp. Med. 2006. 203: 1033-1043.
17. Cooper, M. A., Fehniger, T. A. and Caligiuri, M. A., The biology of human natural killer-cell subsets. Trends Immunol. 2001. 22: 633-640.
18. Vivier, E., Sorrell, J. M., Ackerly, M., Robertson, M. J., Rasmussen, R. A., Levine, H. and Anderson, P., Developmental regulation of a mucinlike glycoprotein selectively expressed on natural killer cells. J. Exp. Med. 1993. 178: 2023-2033.
19. Grzywacz, B., Kataria, N., Sikora, M., Oostendorp, R. A., Dzierzak, E. A., Blazar, B. R., Miller, J. S. and Verneris, M. R., Coordinated acquisition of inhibitory and activating receptors and functional properties by developing human natural killer cells. Blood 2006. 108: 3824-3833.
20. Morita, C. T., Mariuzza, R. A. and Brenner, M. B., Antigen recognition by human gamma delta T cells: Pattern recognition by the adaptive immune system. Springer Semin. Immunopathol. 2000. 22: 191-217.
21. Groh, V., Steinle, A., Bauer, S. and Spies, T., Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells. Science 1998. 279: 1737-1740.
22. Sallusto, F., Lenig, D., Forster, R., Lipp, M. and Lanzavecchia, A., Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999. 401: 708-712.
23. + T cells reflecting their function: Inverse correlation between quantitative expression of CD27 and cytotoxic effector function. Eur. J. Immunol. 2004. 34: 999-1010.
24. + cytotoxic T lymphocyte clones. J. Immunol. 1982. 129: 2001-2003.
25. + T lymphocytes with cellular maturation. J. Exp. Med. 2006. 203: 2865-2877.
26. + T cells specific for human cytomegalovirus. Eur. J. Immunol. 2006. 36: 3198-3206.
27. Platsoucas, C. D., Galinski, M., Kempin, S., Reich, L., Clarkson, B. and Good, R. A., Abnormal T lymphocyte subpopulations in patients with B cell chronic lymphocytic leukemia: An analysis by monoclonal antibodies. J. Immunol. 1982. 129: 2305-2312.
28. Scrivener, S., Goddard, R. V., Kaminski, E. R. and Prentice, A. G., Abnormal T-cell function in B-cell chronic lymphocytic leukaemia. Leuk. Lymphoma 2003. 44: 383-389.
29. Farace, F., Orlanducci, F., Dietrich, P. Y., Gaudin, C., Angevin, E., Courtier, M. H., Bayle, C. et al., T cell repertoire in patients with B chronic lymphocytic leukemia. Evidence for multiple in vivo T cell clonal expansions. J. Immunol. 1994. 153: 4281-4290.
30. Rezvany, M. R., Jeddi-Tehrani, M., Wigzell, H., Osterborg, A. and Mellstedt, H., Leukemia-associated monoclonal and oligoclonal TCR-BV use in patients with B-cell chronic lymphocytic leukemia. Blood 2003. 101: 1063-1070.
31. Gorgun, G., Holderried, T. A., Zahrieh, D., Neuberg, D. and Gribben, J. G., Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells. J. Clin. Invest. 2005. 115: 1797-1805.
32. Li, F. J., Ding, S., Pan, J., Shakhmatov, M. A., Kashentseva, E.,Wu, J., Li, Y. et al., FCRL2 expression predicts IGHV mutation status and clinical progression in chronic lymphocytic leukemia. Blood 2008. 112: 179-187.
33. Vivier, E. and Daeron, M., Immunoreceptor tyrosine-based inhibition motifs. Immunol. Today 1997. 18: 286-291.
34. Meyaard, L., Adema, G. J., Chang, C., Woollatt, E., Sutherland, G. R., Lanier, L. L. and Phillips, J. H., LAIR-1, a novel inhibitory receptor expressed on human mononuclear leukocytes. Immunity 1997. 7: 283-290.
35. Cheson, B. D., Bennett, J. M., Grever, M., Kay, N., Keating, M. J., O'Brien, S. and Rai, K. R., National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: Revised guidelines for diagnosis and treatment. Blood 1996. 87: 4990-4997.